Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
IRadimed Corporation
Market Cap
$1.09B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.06B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10B
Interest Coverage Ratio
-36.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.05B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Interest Coverage Ratio
5.51x
TTM Avg
6.14x
3Y Avg
19.44x
5Y Avg
31.00x
Market Cap
$1.04B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Interest Coverage Ratio
-192.41x
TTM Avg
28.86x
3Y Avg
28.86x
5Y Avg
28.86x
Market Cap
$1.04B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRadimed Corporation (IRMD) | $1.09B | N/A | N/A | N/A | N/A |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.06B | N/A | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL)vs › | $1.10B | -36.11x | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.34x | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 5.51x | 6.14x | 19.44x | 31.00x |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.04B | -192.41x | 28.86x | 28.86x | 28.86x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -497.79x | 15.03x | 15.03x | 8.31x |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.60x | 1.00x | 0.57x | 0.46x |
Interest Coverage
N/A
Debt/Equity
0.00
Current Ratio
9.46
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
